Prof Charlotte Cunningham-Rundles MD PhD is the David S. Gottesman Professor of Medicine and Pediatrics at the Icahn School of Medicine at Mount Sinai in New York.  She is a graduate of Duke University, received her MD from Columbia College of Physicians and Surgeons in New York, and her PhD from New York University School of Medicine. She did internship and residency in Internal Medicine at Bellevue / NYU.  After working at Memorial Sloan Kettering Cancer Center, she was recruited to Mount Sinai Medical Center where she established and directs the Immune Deficiency program. She established and directed the Immune Deficiency program at Mount Sinai and is the Director of the Therapeutic Infusion Service. She has been the Program Director of the Allergy Immunology Fellowship Training Program and previous Chief of Clinical Immunology at Mount Sinai. She is a Past President of CIS and has served on the Board of Directors of the American Academy of Asthma Allergy Immunology (AAAAI).  She has served review committees of the NIH, NASA, and the FDA and was a founding member of the NIH supported consortium, USIDNET. She serves on the Medical Advisory Boards of the IDF and the Jeffrey Modell Foundation. She has been a long-standing member and is an officer of the Expert Committee on Inborn Errors of Immunity of the IUIS.   Her research work, supported by the NIH for many years, has been on the cellular, molecular and genetic defects of antibody production.  

Prof Charlotte Cunningham-Rundles has received the Clinical Immunology Society President’s Award, Jefferey Model Foundation’s Life Time Achievement Award, the Boyle Award from Immune Deficiency Foundation, the AAAAI Research Award, the Abbott Award from the American Society for Microbiology and the Distinguished Physician Award from the AAAAI, the Boyle Award, Immune Deficiency Foundation the David McCourtie Award from the Canadian Society of Allergy and Clinical Immunology, the Virginia Kneeland Franz Award from Columbia College of Physicians and Surgeons and the 2024 Joachim Hilfenhaus Award for Immunology Excellence from the Plasma Protein Therapeutics Association.